“Bad Luck” in Cancer Diagnosis, Lifestyle Guidelines, Pfizer’s Ibrance and More…

Here are a few highlights of cancer research news that have recently caught my attention:

  • Developing cancer may be simply due to “bad luck”, according to a recently published article in Science.
  • Scientists have started clinical trials to test drugs for a gene mutation linked to multiple cancers. More on these trials can be found in journal Cancer Discovery.
  • Lifestyle guidelines may reduce certain cancer risks and overall mortality. For more, please refer to this article in the American Journal of Clinical Nutrition.
  • Stereotactic body radiation therapy plus chemotherapy improves survival rates of stage 4 lung cancer patients according to study at UT Southwestern Medical Center published in the Journal of Clinical Oncology.
  • Pfizer’s Ibrance, new cancer drug type to treat advanced breast cancer, may get early approval.
  • According to the latest annual report from the American Cancer Society, death rates from cancer continue to drop in the US.

.Please feel free to contact Marisol Hernandez to share any comments.

Promising News on Herceptin, Aspirin, NSAIDS and More…

Here are a few highlights of cancer research news that have recently caught my attention:

  • The American Medical Association has updated Current Procedural Terminology (CPT) codes for image-guided breast biopsies.
  • Herceptin has been found to greatly improve long-term survival of her2-positive breast cancer. More on this study can be found in the Journal of Clinical Oncology.
  • Researchers at Georgia Institute of Technology have identified one gene that allows breast cancer cells to break free and spread in the body. It’s a discovery that could lead to a way to block or slow the spread of the disease. You can read more about this study in Journal of the Federation of American Societies for Experimental Biology (FASEB).
  • Aspirin and NSAIDS may reduce skin cancer risk. Researchers at Berghofer Medical Research Institute, Brisbane Queensland Australia discuss their findings in the Journal of Investigative Dermatology.
  • Physical activity has been show to improve the survival rate for men with localized prostate cancer. The findings have been published in the journal Cancer Epidemiology, Biomarkers & Prevention.
  • Researchers at the Medical College of Wisconsin have found a link between sleep deprivation and cell damage. More on their findings in the December issue of Sleep.

Please feel free to contact Marisol Hernandez to share any comments.

Tamoxifen, Smokeless Tobacco, Vocal-Cord Cancer and More…

Here are a few highlights of cancer research news that have recently caught my attention:

  • The latest study concerning Tamoxifen and breast cancer prevention demonstrates mixed results. Findings were published in the Lancet Oncology.
  • The Center for Disease Control (CDC) and the National Cancer Institute have released the first report on the use of smokeless tobacco at a global level.
  • Investigators at Dana-Farber and MIT found that the agent THZ1 caused small cell lung cancer tumors to shrink in mice. Their findings are published in Cancer Cell.
  • Giving cells a boost during chemo is the focus of a recent paper published by scientists at Michigan State University.
  • In a recent publication, researchers at the Centenary Institute in Australia demonstrated that if you stop cells from moving, you can stop cancer from growing.
  • Patients that have undergone laser treatment for vocal cord cancer have shown positive outcomes. Find out more about this intervention in the latest issue of Annals of Otology, Rhinology and Laryngology.

Please feel free to contact Marisol Hernandez to share any comments.